Delivery Order SPE2DB24D2100-SPE2DB24FBCSH

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,714.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565218807 - Hydroxyzine 10 mg/5 ml Syrup 473 ml, a pharmaceutical product. The contract has an ultimate completion date of July 23, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside designation. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,152.12 and is a Firm Fixed Price Delivery Order for the supply of 4563850006 - Hydroxyzine 10 mg/5 ml Syrup 473 ml. The contract has an ultimate completion date of March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,532.05, is for the delivery of Hydroxyzine 10 mg/5 ml syrup in 473 ml quantities. The contract has an ultimate completion date of March 7, 2024, and utilizes a firm fixed-price delivery order pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4563343774 - Hydroxyzine 10 mg/5 ml Syrup 473 ml, with a ceiling value of $3,388.40 and a performance period through January 18, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,004.92 firm fixed price delivery order is for the supply of 4564377466 - Hydroxyzine 10 mg/5 ml syrup in 473 ml bottles. This contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,759.16 delivery order is for the supply of 473 ml of Hydroxyzine 10 mg/5 ml syrup, with a completion date of July 3, 2023. This award is a firm fixed-price contract and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,339.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566171648 - HYDROXYZINE 10 MG/5 ML SYRUP 473ML, with a completion date of October 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. In addition to this specific award, AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of hydroxyzine 50 mg/ml vial. The award, valued at $1,043.80, is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This IDC enables the DLA to efficiently...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,777.13, is for the delivery of hydroxyzine 50 mg/mL vials. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,074.48 firm fixed price delivery order is for the supply of 4565032831 - Hydroxyzine 50 mg/ml vial. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCSH
    Delivery Order

This federal contract award, valued at $3,715.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4565295944 - Hydroxyzine 10 mg/5 ml syrup 473 ml to support military treatment programs and facilities. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply critical care materials and medications to various defense and civilian agencies, including the Department of Justice Federal Bureau of Investigation.

Generated 10/29/24, 9:19 AM